Current Research on HIV Drug Resistance
HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advanc...
Guardado en:
| Formato: | Online |
|---|---|
| Lenguaje: | inglés |
| Publicado: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Materias: | |
| Acceso en línea: | ONIX_20221206_9783036555119_8 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1869514952641871872 |
|---|---|
| collection | Directory of Open Access Books |
| description | HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advancements in HIV resistance diagnosis, surveillance and research. This book compiles all articles published in this collection, combining original research and review articles on HIV drug resistance. |
| format | Online |
| id | doab-20.500.12854ir-94485 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-944852024-03-31T13:10:30Z Current Research on HIV Drug Resistance Ji, Hezhao HIV drug resistance sanger sequencing next-generation sequencing interrupted antiretroviral therapy HIV-1 nef Botswana drug resistance mutations 3′-polypurine tract dolutegravir single genome sequencing drug resistance integrase strand transfer inhibitors replication fitness case study complex adaptive system leverage points systems mapping Dar es Salaam Tanzania HIV surveillance public health Mexico HIV pretreatment drug resistance HIV acquired drug resistance Mexico City antiviral therapy protease inhibitor protease mutation atazanavir HCV probe capture enrichment point-of-care test resource-limited setting testing analytes specimens performance n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advancements in HIV resistance diagnosis, surveillance and research. This book compiles all articles published in this collection, combining original research and review articles on HIV drug resistance. 2022-12-06T16:07:42Z 2022-12-06T16:07:42Z 2022 book ONIX_20221206_9783036555119_8 9783036555119 9783036555126 https://directory.doabooks.org/handle/20.500.12854/94485 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/6309 https://mdpi.com/books/pdfview/book/6309 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-5512-6 10.3390/books978-3-0365-5512-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036555119 9783036555126 152 Basel open access |
| spellingShingle | HIV drug resistance sanger sequencing next-generation sequencing interrupted antiretroviral therapy HIV-1 nef Botswana drug resistance mutations 3′-polypurine tract dolutegravir single genome sequencing drug resistance integrase strand transfer inhibitors replication fitness case study complex adaptive system leverage points systems mapping Dar es Salaam Tanzania HIV surveillance public health Mexico HIV pretreatment drug resistance HIV acquired drug resistance Mexico City antiviral therapy protease inhibitor protease mutation atazanavir HCV probe capture enrichment point-of-care test resource-limited setting testing analytes specimens performance n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics Current Research on HIV Drug Resistance |
| title | Current Research on HIV Drug Resistance |
| title_full | Current Research on HIV Drug Resistance |
| title_fullStr | Current Research on HIV Drug Resistance |
| title_full_unstemmed | Current Research on HIV Drug Resistance |
| title_short | Current Research on HIV Drug Resistance |
| title_sort | current research on hiv drug resistance |
| topic | HIV drug resistance sanger sequencing next-generation sequencing interrupted antiretroviral therapy HIV-1 nef Botswana drug resistance mutations 3′-polypurine tract dolutegravir single genome sequencing drug resistance integrase strand transfer inhibitors replication fitness case study complex adaptive system leverage points systems mapping Dar es Salaam Tanzania HIV surveillance public health Mexico HIV pretreatment drug resistance HIV acquired drug resistance Mexico City antiviral therapy protease inhibitor protease mutation atazanavir HCV probe capture enrichment point-of-care test resource-limited setting testing analytes specimens performance n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics |
| topic_facet | HIV drug resistance sanger sequencing next-generation sequencing interrupted antiretroviral therapy HIV-1 nef Botswana drug resistance mutations 3′-polypurine tract dolutegravir single genome sequencing drug resistance integrase strand transfer inhibitors replication fitness case study complex adaptive system leverage points systems mapping Dar es Salaam Tanzania HIV surveillance public health Mexico HIV pretreatment drug resistance HIV acquired drug resistance Mexico City antiviral therapy protease inhibitor protease mutation atazanavir HCV probe capture enrichment point-of-care test resource-limited setting testing analytes specimens performance n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics |
| url | ONIX_20221206_9783036555119_8 |